Reovirus infections in poultry are caused by avian orthoreoviruses belonging to the family Reoviridae, which produce a range of disease syndromes affecting the musculoskeletal system, gastrointestinal tract, and immune system of chickens and turkeys. The most economically significant manifestation is viral arthritis/tenosynovitis, a condition characterized by inflammation and rupture of tendons and ligaments that causes severe lameness and substantial economic losses in broiler and meat-type chicken production. Reoviruses are ubiquitous in poultry populations worldwide, though the severity of disease depends on viral strain pathogenicity, host factors, and management conditions.
Avian reoviruses affect chickens of all ages, though clinical disease typically manifests in young broilers between 3 and 8 weeks of age, coinciding with the period of rapid growth and increasing body weight that stresses developing tendons and joints. Turkeys develop similar arthritis syndromes, while other poultry species appear less frequently affected. The viruses are extremely stable in the environment and resistant to many common disinfectants, facilitating persistence in poultry houses and transmission between flocks. Vertical transmission from infected breeder hens to offspring through the egg is an important epidemiological feature that perpetuates infection in commercial poultry operations.
The economic impact of reovirus infections in the poultry industry is substantial, particularly in broiler production where the viral arthritis/tenosynovitis syndrome causes lameness, reduced growth rates, increased condemnations at processing, and secondary welfare concerns. Runting-stunting syndrome associated with certain reovirus strains causes severe growth retardation and uniformity problems that reduce flock value. Immunosuppressive effects of reovirus infection may exacerbate responses to other pathogens, compounding production losses. While mortality directly attributed to reovirus is typically low, the production impact and welfare implications make this an important economic disease.
Control of reovirus infections relies on vaccination programs that establish maternal immunity in breeder hens, transferring protective antibodies to offspring through the egg yolk. This maternal antibody protection covers the critical early growth period when chicks are most susceptible to severe disease. Maintaining strict biosecurity and hygiene practices helps reduce environmental viral loads and challenge pressure. Understanding the diversity of reovirus strains circulating in a region and their relationship to vaccine strains is essential for designing effective control programs. Working with poultry veterinarians to implement appropriate vaccination schedules and monitor flock health provides the foundation for minimizing reovirus impact.
